NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and Cancer Research UK, the world’s largest charitable funder of cancer research, today announced that the Medidata Clinical Cloud® has been selected to support the charity’s ground-breaking drug discovery research. In collaboration with academic and industry partners, Cancer Research UK’s Centre for Drug Development (CDD) translates exciting new discov
| < Prev | Next > |
|---|
